Comparing cancer detection rates of patients undergoing short term follow-up vs routine follow-up after benign breast biopsies, is follow-up needed?

Donna M. Plecha; Courtney Garlick; Christina Dubchuck; Cheryl Thompson; Niki Constantinou

doi:10.1016/j.clinimag.2016.11.007

Comparing cancer detection rates of patients undergoing short term follow-up vs routine follow-up after benign breast biopsies, is follow-up needed?

Donna M. Plecha, Courtney Garlick, Christina Dubchuck, Cheryl Thompson, Niki Constantinou

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Purpose To compare cancer rates after benign breast biopsies between patients with short term imaging follow-up (STFU) and those with routine follow-up (RFU). Materials & methods Retrospective review of benign stereotactic, US or DCE-MRI breast biopsies. Results Of 580 lesions, 192 (33%) had STFU, and 388 (67%) had RFU. For US and mammographic detected lesions, there is no difference in cancer rates between the STFU (1 cancer, n = 148) and the RFU group (0 cancer, n = 365) (p = 0.29). There were 2 cancers in the STFU group versus 0 in the RFU DCE-MRI group (p = 0.54). Conclusion Our results support RFU after benign ultrasound and stereotactic breast biopsies.

Original language	English (US)
Pages (from-to)	37-42
Number of pages	6
Journal	Clinical Imaging
Volume	42
DOIs	https://doi.org/10.1016/j.clinimag.2016.11.007
State	Published - Mar 1 2017

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.clinimag.2016.11.007

Cite this

@article{f9690da297e04f0c802cf94fea1656e1,

title = "Comparing cancer detection rates of patients undergoing short term follow-up vs routine follow-up after benign breast biopsies, is follow-up needed?",

abstract = "Purpose To compare cancer rates after benign breast biopsies between patients with short term imaging follow-up (STFU) and those with routine follow-up (RFU). Materials & methods Retrospective review of benign stereotactic, US or DCE-MRI breast biopsies. Results Of 580 lesions, 192 (33%) had STFU, and 388 (67%) had RFU. For US and mammographic detected lesions, there is no difference in cancer rates between the STFU (1 cancer, n = 148) and the RFU group (0 cancer, n = 365) (p = 0.29). There were 2 cancers in the STFU group versus 0 in the RFU DCE-MRI group (p = 0.54). Conclusion Our results support RFU after benign ultrasound and stereotactic breast biopsies.",

author = "Plecha, {Donna M.} and Courtney Garlick and Christina Dubchuck and Cheryl Thompson and Niki Constantinou",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2017",

month = mar,

day = "1",

doi = "10.1016/j.clinimag.2016.11.007",

language = "English (US)",

volume = "42",

pages = "37--42",

journal = "Clinical Imaging",